wells pharma logo
Register Now
Order Now

Learn About Wells Pharma

Excellence in 503B Outsourcing
When It Matters Most

Wells Pharma of Houston is a nationally recognized 503B outsourcing partner providing sterile, ready-to-use medications that hospitals and surgery centers depend on for safety, consistency, and speed.

We were founded on a simple principle: to deliver pharmaceutical-grade quality, consistency, and reliability that supports patient care from the emergency room to surgery centers.

Every product we compound, every batch we release, and every shipment we send reflects our commitment to safety, compliance, and responsiveness.

Our Mission

To be the most trusted 503B outsourcing partner for healthcare institutions, delivering high-quality, ready-to-use sterile solutions that enhance patient safety, improve efficiency, and ensure uninterrupted access to essential medications.

The 5Cs framework can be presented visually for better readability:

  • Customer Service: responsive, transparent, and solution driven.
  • Confidence in Quality: rigorous standards under cGMP and USP guidelines.
  • Consistent Supply: proven reliability during national shortages.
  • Comprehensive Portfolio: syringes, admixtures, vials, and drug-shortage meds.
  • Competitive Price: maximizing value without compromising safety.

Our Commitment to Quality

Our quality systems are routinely audited by regulatory authorities and leading health systems nationwide.

Wells Pharma operates under current Good Manufacturing Practices (cGMP) and in accordance with USP <797>, <788>, and <85> standards.

Each product is:
  • Sterile-to-sterile compounded for maximum safety
  • Endotoxin and particulate tested prior to release
  • Batch-verified and quality-assured by a dedicated compliance team

Our facility utilizes advanced cleanroom technology and continuous environmental monitoring to meet the highest regulatory expectations.

Reliable Supplier

Our team continuously monitors supply chain conditions, anticipates potential shortages, and adjusts production strategies to help partners maintain reliable access to essential sterile medications.

This level of planning and operational flexibility allows Wells Pharma to support healthcare organizations with consistent supply, dependable turnaround times, and the confidence that patient care will not be compromised by medication shortages.

For hospitals and health systems navigating today’s complex supply environment, Wells Pharma serves as a trusted outsourcing partner, helping safeguard medication availability and support uninterrupted patient care.

Our Team Members

At Wells Pharma, our leadership team brings together years of expertise from across the healthcare and pharmaceutical industries. As a trusted 503B Outsourcing Facility, we combine innovation, science, and service to deliver ready-to-use sterile compounding solutions that exceed the expectations of hospitals, surgery centers, and patients nationwide.

Andy Corbin

President and Chief Financial Officer
Linkedin
Carissa Imrecke

Carissa Imrecke, MBA, BS

Vice President of Quality
Linkedin

Stan Pflueger

Senior Vice President of Sales and Marketing
Linkedin
David Koch

David Koch

Vice President of Sales

Linkedin

Enhancing the Healthcare Industry.
Wells Pharma of Houston.

Your Trusted 503B Partner in Patient Care

We’re passionate about service and dedicated to supporting patient-first care. Let’s connect today to discuss how we can meet your 503B outsourcing needs.

Download Product Catalog
Order Now

Questions? We are here to help.

Andy Corbin

____ President and Chief Financial Officer

Andy is an accomplished executive leader in operations, finance, and technology-driven systems with more than 20 years of experience in the healthcare, digital healthcare, and pharmaceutical compounding facilities.

He joins Wells Pharma of Houston, LLC. as CFO. Andy has held several C-Level positions with Sage Software Healthcare Division, StayWell Health Management, LifeLock, and most notably as WebMD’s Corporate CFO and CEO of WebMD Practice Services Software Division.

Most recently Andy was President and CFO at a 503B Outsourcing Facility where he opened and operated a built-for-purpose 42,000 square-foot manufacturing plant. Andy’s wealth of experience makes him a great addition to the Wells Pharma Team.

Carissa Imrecke, MBA, BS

_________ Vice President of Quality
Carissa Imrecke is Vice President of Quality at Wells Pharma of Houston. She began her career in the pharmaceutical industry as a microbiologist, building hands-on experience in quality control and quality assurance. She then moved into healthcare, leading multi-site quality and operations programs that broadened her scope to risk management, occupational safety, and emergency management preparedness. Returning to pharma, she now leads Quality, standardizing and simplifying systems, strengthening investigation discipline, and making performance visible through leadership scorecards and documented decision criteria. She holds a Lean Six Sigma Green Belt. Prior board service includes President, AOHP Southwest Chapter; Regional Director, AOHP National Board; and Vice President, Fort Bend Women’s Center STARS. She was recognized in the National Safety Council’s Rising Stars of Safety as one of 40 honorees worldwide under age 40. Her work is guided by a simple goal: protect every patient and strengthen the communities that depend on safe, reliable medicine.

Stan Pflueger

____ Senior Vice President of Sales and Marketing

Stan has developed a unique and formidable combination of administrative, analytical and sales skills that have allowed him to make valuable contributions to the pharmaceutical companies with whom he has partnered during his 10-year career. While at Avella Specialty Pharmacy, Stan leveraged his Six Sigma certification to identify and implement strategies to reduce costs and grow revenue. At Avella (later Optum) Stan designed and implemented a project to identify lost accounts which recovered $14M in revenue 18 months post implementation, and he built the value of government contracts from $750K in 2017 to $47.8M in 2019.

Most recently, at Wells Pharma of Houston, Stan has been the architect for the development and implementation of the company’s CRM and leads the Sales and Customer Service teams responsible for an average annual revenue growth of 213% since 2021. He led the team responsible for securing and maintaining Wells Pharma’s licensure for the 50 states in which the company operates. Stan is also responsible for the production scheduling for Wells Pharma.

David Koch

____ Senior Vice President of Sales

David Koch serves as Vice President of Sales at Wells Pharma, where he leads the company’s national sales organization and commercial growth strategy across the acute care and health-system pharmacy markets. David plays a key role in shaping Wells Pharma’s customer engagement strategy, strengthening relationships with hospitals, health systems, IDNs, and GPO partners, and supporting the company’s continued growth as a trusted 503B outsourcing partner.

David brings extensive commercial leadership experience across the healthcare, pharmaceutical, medical device, and healthcare services industries. He has a proven track record of building high-performing sales organizations, developing strategic customer partnerships, and driving sustainable growth in highly competitive healthcare markets.

David’s leadership approach is rooted in relationship-building, communication, and collaboration. He is passionate about helping organizations expand market presence while delivering exceptional service and support to healthcare providers and their patients. David is committed to aligning customer needs with Wells Pharma’s broader business priorities, helping ensure the company remains responsive, strategic, and focused on delivering value to the pharmacy and healthcare communities.

Prior to joining Wells Pharma, David held commercial and sales leadership roles with organizations including BioTE Medical, Hologic, Xenex Disinfection Services, Natus Medical, Huron Consulting Group, AngioDynamics, and Cynosure.

A graduate of Auburn University, David brings extensive industry knowledge, executive sales leadership, and a customer-focused approach to Wells Pharma as the company continues to expand its impact across the pharmacy and healthcare landscape.